{"id":11024,"date":"2026-10-27T03:00:58","date_gmt":"2026-10-27T07:00:58","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=11024"},"modified":"2026-10-27T03:16:18","modified_gmt":"2026-10-27T07:16:18","slug":"medicure-gains-5-percent-to-7-year-closing-high-must-see-biotech-stock-screen","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/medicure-gains-5-percent-to-7-year-closing-high-must-see-biotech-stock-screen\/","title":{"rendered":"Medicure Gains 4.76% to 7-Year Closing High of $4.40: Must See Biotech Stock Screen"},"content":{"rendered":"\n
\n\n

\nNIA’s latest brand-new stock suggestion<\/span> Medicure (TSXV: MPH) gained by 4.76%<\/span><\/strong> today to a 7-year closing high<\/strong><\/span> of $4.40 per share<\/strong>:\n<\/p>\n\n

\n\"Medicure\n<\/p>\n\n

\nNIA has just conducted<\/strong><\/span> a stock screen<\/strong><\/span> of all<\/span> biotech companies<\/strong> listed in the U.S. or Canada including the U.S. OTC which includes a large percentage of foreign listed biotech stocks. There are 494 biotech stocks<\/strong> with a market cap<\/strong> of US$5 million<\/strong> or above<\/strong><\/span> listed on either the NYSE, NYSE American, NASDAQ, OTC Markets, TSX, TSX Venture, or CSE.\n<\/p>\n\n

\nWe filtered<\/strong><\/span> these 494 biotech stocks<\/strong> for companies that are: 1) generating<\/span> revenue<\/strong>, 2) have positive net cash<\/span> positions<\/strong>, 3) have seen no dilution<\/strong><\/span> in the trailing twelve months<\/strong>, 4) have seen no dilution<\/strong><\/span> in the trailing ten years<\/strong>.\n<\/p>\n\n

\nThese are the remaining<\/span> 1% of biotech companies<\/strong> that meet<\/strong><\/span> the above<\/span> criteria<\/strong>:\n<\/p>\n\n

\n\"Biotech\n<\/p>\n\n

\nOnly 5 out of 494 biotech stocks<\/strong> met the criteria<\/strong><\/span> and Medicure (TSXV: MPH)<\/strong> is by far the lowest<\/span> market cap<\/strong> of the five. Medicure (TSXV: MPH)<\/strong> has a 100% chance<\/strong><\/span> of becoming one of NIA’s largest percentage gainers of all-time<\/span><\/strong> we are 100% sure<\/span><\/strong> of it!\n<\/p>\n\n

\nWatch what happens. We will be proven right.\n<\/p>\n\n

\nPast performance is not indicative of future results. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA’s President has purchased 87,000 shares of MPH and intends to buy more shares. This communication is for informational and educational purposes only.<\/em>\n<\/p>\n\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

NIA’s latest brand-new stock suggestion Medicure (TSXV: MPH) gained by 4.76% today to a 7-year closing high of $4.40 per share: NIA has just conducted a stock screen of all biotech companies listed in the U.S. or Canada including the U.S. OTC which includes a large percentage of foreign listed biotech stocks. There are 494 […]<\/p>\n","protected":false},"author":1,"featured_media":11027,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[365,414],"class_list":["post-11024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-biotech","tag-mph"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=11024"}],"version-history":[{"count":2,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11024\/revisions"}],"predecessor-version":[{"id":11029,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11024\/revisions\/11029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/11027"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=11024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=11024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=11024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}